bioMérieux S.A. (EPA:BIM)
France · Delayed Price · Currency is EUR 113.00
+1.00 (0.89%)
Sep 26, 2025, 5:37 PM CET
bioMérieux Market Cap
bioMérieux has a market cap or net worth of €13.34 billion as of September 26, 2025. Its market cap has increased by 5.37% in one year.
Market Cap
13.34B
Enterprise Value
13.47B
Revenue
4.12B
Ranking
n/a
PE Ratio
35.65
Stock Price
€113.00
Market Cap Chart
Since July 7, 2004, bioMérieux's market cap has increased from 1.18B to 13.34B, an increase of 1,027.19%. That is a compound annual growth rate of 12.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2025 | 13.34B | 9.24% |
| Dec 31, 2024 | 12.21B | 2.78% |
| Dec 29, 2023 | 11.88B | 2.52% |
| Dec 30, 2022 | 11.59B | -21.58% |
| Dec 31, 2021 | 14.78B | 8.25% |
| Dec 31, 2020 | 13.65B | 45.70% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 122.67B |
| Sanofi | 94.33B |
| Sartorius Stedim Biotech | 16.98B |
| Eurofins Scientific SE | 10.83B |
| Ipsen | 9.18B |
| ABIVAX Société Anonyme | 5.30B |
| Virbac | 2.60B |
| emeis Société anonyme | 2.18B |